Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Cash Flow Reinvestment Rate
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥84.38 Million (capex CN¥84.38 Million ) from operating cash flow of CN¥446.51 Million. Explore reinvestment intensity of Shijiazhuang Yiling Pharmaceutical Co Lt to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shijiazhuang Yiling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Shijiazhuang Yiling Pharmaceutical Co Ltd across 17 annual periods. Also explore Shijiazhuang Yiling Pharmaceutical Co Lt assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Shijiazhuang Yiling Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Shijiazhuang Yiling Pharmaceutical Co Lt market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | CN¥1.00 Billion | CN¥1.78 Billion | CN¥245.62 Million | ▼ -84.3% |
| 2024 | 3.59x | CN¥2.19 Billion | CN¥611.01 Million | CN¥290.39 Million | ▼ -53.9% |
| 2023 | 7.78x | CN¥1.21 Billion | CN¥155.46 Million | CN¥310.83 Million | ▲ +1129.1% |
| 2022 | 0.63x | CN¥2.21 Billion | CN¥3.49 Billion | CN¥213.98 Million | ▼ -59.8% |
| 2021 | 1.58x | CN¥832.89 Million | CN¥528.69 Million | CN¥673.56 Million | ▲ +104.2% |
| 2020 | 0.77x | CN¥1.22 Billion | CN¥1.59 Billion | CN¥1.14 Billion | ▼ -94.2% |
| 2019 | 13.23x | CN¥912.02 Million | CN¥68.93 Million | CN¥454.43 Million | ▲ +147.9% |
| 2018 | 5.34x | CN¥386.34 Million | CN¥72.37 Million | CN¥187.23 Million | ▼ -36.7% |
| 2017 | 8.43x | CN¥966.75 Million | CN¥114.65 Million | CN¥180.35 Million | ▲ +516.0% |
| 2016 | 1.37x | CN¥877.97 Million | CN¥641.45 Million | CN¥373.03 Million | ▼ -78.6% |
| 2015 | 6.41x | CN¥845.18 Million | CN¥131.88 Million | CN¥478.43 Million | ▲ +50.8% |
| 2014 | 4.25x | CN¥450.19 Million | CN¥105.90 Million | CN¥450.19 Million | ▼ -42.6% |
| 2013 | 7.41x | CN¥409.83 Million | CN¥55.32 Million | CN¥409.83 Million | ▲ +75.0% |
| 2012 | 4.23x | CN¥296.89 Million | CN¥70.13 Million | CN¥296.89 Million | ▲ +345.2% |
| 2010 | 0.95x | CN¥285.02 Million | CN¥299.72 Million | CN¥285.02 Million | ▲ +43.7% |
| 2009 | 0.66x | CN¥210.57 Million | CN¥318.21 Million | CN¥210.57 Million | ▲ +8.4% |
| 2008 | 0.61x | CN¥128.27 Million | CN¥210.18 Million | CN¥128.27 Million | — |